Qiagen N.V. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,302
1,345
1,281
1,338
1,418
1,502
Cost of Goods Sold (COGS) incl. D&A
471
464
493
517
527
536
Gross Income
831
881
788
821
891
966
SG&A Expense
618
687
614
626
669
667
EBIT
214
189
174
192
218
299
Unusual Expense
155
101
8
112
59
63
Non Operating Income/Expense
7
6
1
9
9
34
Interest Expense
31
38
37
39
50
67
Pretax Income
37
51
132
57
114
226
Income Tax
32
8
6
23
74
35
Equity in Affiliates
-
3
-
-
-
-
Consolidated Net Income
69
46
127
80
40
190
Net Income
69
45
127
80
40
190
Net Income After Extraordinaries
69
45
127
80
40
190
Net Income Available to Common
69
45
127
80
40
190
EPS (Basic)
0.31
0.20
0.56
0.35
0.17
0.82
Basic Shares Outstanding
225
224
225
226
228
227
EPS (Diluted)
0.30
0.20
0.56
0.35
0.17
0.82
Diluted Shares Outstanding
233
227
228
230
233
233
EBITDA
413
399
365
405
435
505
Other Operating Expense
-
5
-
4
3
-
Non-Operating Interest Income
2
6
5
7
11
21
Minority Interest Expense
-
1
-
-
-
-
Equity in Affiliates (Pretax)
-
-
-
-
3
3

About Qiagen

View Profile
Address
Hulsterweg 82
Venlo Limburg 5912 PL
Netherlands
Employees -
Website http://www.qiagen.com
Updated 07/08/2019
QIAGEN NV is a holding company, which engages in the manufacture and distribution of sample and assay technology products for preanalytical sample preparations. It provides solutions to customers that are classified into molecular diagnostics, applied testing, pharma, and academia. Its products include instruments, and consumables and related products.